Physician profile
John C Dean
NPI 1013923291
$7,344.06
in general payments reported to CMS, 2019-2025
18 companies · $63.41 in 2025
The $63.41 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,717 · 2020: $161 · 2021: $130 · 2022: $91.90 · 2023: $120 · 2024: $60.12 · 2025: $63.41.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $244.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $243.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $5,751.73 | 2019 | |
| Rattan and Associates | $609.99 | 2019 | |
| Horizon Therapeutics Plc | $238.22 | 2019-2020 | |
| Pacira Therapeutics, INC. | $212.80 | 2019-2021 | |
| Smith+Nephew, INC. | $120.10 | 2019 | |
| Amgen INC. | $97.41 | 2021-2025 | Krystexxa, Evenity, Prolia |
| Pacira Pharmaceuticals Incorporated | $49.67 | 2022-2023 | Zilretta, Iovera, Exparel |
| Biomerieux INC | $44.20 | 2023 | |
| Integra Lifesciences Corporation | $38.96 | 2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Zyla Life Sciences, INC. | $28.89 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $27.22 | 2022 | |
| Orthofix Medical, INC. | $25.50 | 2024-2025 | Physio-Stim |
| Bioventus LLC | $21.50 | 2023 | Durolane |
| Vertex Pharmaceuticals Incorporated | $20.47 | 2025 | |
| Sanofi-Aventis U.S. LLC | $17.57 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heron Therapeutics, INC. | $17.54 | 2022 | |
| Radius Health, INC. | $13.00 | 2022 | |
| Advanced Oxygen Therapy INC. | $9.29 | 2025 | Topical Oxygen Chamber For Extremities |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Dean listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.